JP2005503382A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005503382A5 JP2005503382A5 JP2003520746A JP2003520746A JP2005503382A5 JP 2005503382 A5 JP2005503382 A5 JP 2005503382A5 JP 2003520746 A JP2003520746 A JP 2003520746A JP 2003520746 A JP2003520746 A JP 2003520746A JP 2005503382 A5 JP2005503382 A5 JP 2005503382A5
- Authority
- JP
- Japan
- Prior art keywords
- physiologically acceptable
- pharmaceutical composition
- acceptable salt
- sumatriptan
- zolmitriptan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10139410A DE10139410A1 (de) | 2001-08-17 | 2001-08-17 | Verwendung von BIBN4096 in Kombination mit anderen Arzneistoffen gegen Migräne für die Behandlung von Migräne |
| PCT/EP2002/008993 WO2003015787A1 (en) | 2001-08-17 | 2002-08-10 | Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005503382A JP2005503382A (ja) | 2005-02-03 |
| JP2005503382A5 true JP2005503382A5 (https=) | 2005-12-22 |
Family
ID=7695082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003520746A Pending JP2005503382A (ja) | 2001-08-17 | 2002-08-10 | 偏頭痛の治療のために他の抗偏頭痛薬と組み合わせたｂｉｂｎ４０９６の使用 |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1420790B1 (https=) |
| JP (1) | JP2005503382A (https=) |
| KR (1) | KR20040027892A (https=) |
| CN (1) | CN1543347A (https=) |
| AR (1) | AR036265A1 (https=) |
| AT (1) | ATE304854T1 (https=) |
| BR (1) | BR0211970A (https=) |
| CA (1) | CA2454083A1 (https=) |
| CO (1) | CO5560577A2 (https=) |
| DE (2) | DE10139410A1 (https=) |
| EA (1) | EA200400253A1 (https=) |
| EC (1) | ECSP044979A (https=) |
| ES (1) | ES2250733T3 (https=) |
| HR (1) | HRP20040150A2 (https=) |
| HU (1) | HUP0401484A3 (https=) |
| IL (1) | IL159879A0 (https=) |
| MX (1) | MXPA04001364A (https=) |
| NO (1) | NO20041024D0 (https=) |
| PL (1) | PL365482A1 (https=) |
| UY (1) | UY27416A1 (https=) |
| WO (1) | WO2003015787A1 (https=) |
| ZA (1) | ZA200400313B (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8465468B1 (en) | 2000-06-29 | 2013-06-18 | Becton, Dickinson And Company | Intradermal delivery of substances |
| DE10207026A1 (de) * | 2002-02-20 | 2003-08-28 | Boehringer Ingelheim Kg | Pulverinhalativum, enthaltend den CGRP-Antagonisten BIBN4096 und Verfahren zu dessen Herstellung |
| EP1374870A1 (en) * | 2002-06-24 | 2004-01-02 | Rita Dobmeyer | Medication for the treatment or prevention of migraine |
| DE10314617A1 (de) * | 2003-04-01 | 2004-10-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung des Hydrochlorids der Wirkstoffbase 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]-carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin in Kombination mit Sumatriptan zur Behandlung von Migräne |
| DE10338407A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Inhalationspulver enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin |
| DE10338402A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknetes, amorphes BIBN 4096, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
| DE10338403A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
| DE10338399A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Mikropartikel, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-Iysyl]-4-(4-pyridinyl)-piperazin, Verfahren zu deren Herstellung sowie deren Verwendung als Inhalaltionspulver |
| US20050065094A1 (en) | 2003-09-05 | 2005-03-24 | Boehringer Ingelheim International Gmbh | Use of telmisartan for the prevention and treatment of vascular headache |
| JP2007533685A (ja) * | 2004-04-20 | 2007-11-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 偏頭痛を治療するためのセロトニン再吸収阻害剤と組合わせたｃｇｒｐアンタゴニストの使用 |
| WO2005115360A2 (en) * | 2004-05-11 | 2005-12-08 | Becton, Dickinson And Company | Formulations of anti-pain agents and methods of using the same |
| DE102004063753A1 (de) * | 2004-12-29 | 2006-07-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung ausgewählter CGRP-Antagonisten in Kombination mit anderen Arzneistoffen gegen Migräne für die Behandlung von Migräne |
| RU2313340C1 (ru) * | 2006-02-20 | 2007-12-27 | Дмитрий Владимирович Зимин | Лекарственное средство, обладающее противомигренозным действием, и способ его изготовления |
| RU2424803C2 (ru) * | 2008-04-07 | 2011-07-27 | Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии имени В.В. Закусова РАМН (НИИ фармакологии имени В.В.Закусова РАМН) | Фармацевтическая композиция с противомигреневым действием (варианты) |
| CN102526031A (zh) * | 2010-12-27 | 2012-07-04 | 湖南九典制药有限公司 | 一种鼻腔内使用的舒马普坦药物组合物及其制备方法 |
| CN103385876B (zh) * | 2012-05-08 | 2016-01-13 | 四川滇虹医药开发有限公司 | 一种夫罗曲坦的药物组合物及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59711622D1 (de) * | 1996-09-10 | 2004-06-17 | Boehringer Ingelheim Pharma | Abgewandelte aminosäuren, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| DE19937304C2 (de) * | 1999-08-10 | 2003-08-21 | Boehringer Ingelheim Pharma | Verwendung von CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen |
-
2001
- 2001-08-17 DE DE10139410A patent/DE10139410A1/de not_active Withdrawn
-
2002
- 2002-08-10 IL IL15987902A patent/IL159879A0/xx unknown
- 2002-08-10 KR KR10-2004-7002356A patent/KR20040027892A/ko not_active Withdrawn
- 2002-08-10 CA CA002454083A patent/CA2454083A1/en not_active Abandoned
- 2002-08-10 WO PCT/EP2002/008993 patent/WO2003015787A1/en not_active Ceased
- 2002-08-10 HR HR20040150A patent/HRP20040150A2/hr not_active Application Discontinuation
- 2002-08-10 HU HU0401484A patent/HUP0401484A3/hu unknown
- 2002-08-10 CN CNA028161327A patent/CN1543347A/zh active Pending
- 2002-08-10 BR BR0211970-6A patent/BR0211970A/pt not_active Application Discontinuation
- 2002-08-10 JP JP2003520746A patent/JP2005503382A/ja active Pending
- 2002-08-10 DE DE60206289T patent/DE60206289T2/de not_active Expired - Fee Related
- 2002-08-10 AT AT02794772T patent/ATE304854T1/de not_active IP Right Cessation
- 2002-08-10 MX MXPA04001364A patent/MXPA04001364A/es unknown
- 2002-08-10 ES ES02794772T patent/ES2250733T3/es not_active Expired - Lifetime
- 2002-08-10 EP EP02794772A patent/EP1420790B1/en not_active Expired - Lifetime
- 2002-08-10 PL PL02365482A patent/PL365482A1/xx not_active Application Discontinuation
- 2002-08-10 EA EA200400253A patent/EA200400253A1/ru unknown
- 2002-08-14 UY UY27416A patent/UY27416A1/es not_active Application Discontinuation
- 2002-08-16 AR ARP020103101A patent/AR036265A1/es unknown
-
2004
- 2004-01-15 ZA ZA200400313A patent/ZA200400313B/xx unknown
- 2004-02-12 CO CO04012009A patent/CO5560577A2/es not_active Application Discontinuation
- 2004-02-16 NO NO20041024A patent/NO20041024D0/no not_active Application Discontinuation
- 2004-02-16 EC EC2004004979A patent/ECSP044979A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005503382A5 (https=) | ||
| RU2003101430A (ru) | Препарат и способ лечения болей | |
| ES2234025T3 (es) | Formulacion de agonistas de 5-ht.t. | |
| US6586458B1 (en) | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs | |
| ES2395268T3 (es) | Noribogaína para el tratamiento del dolor y la drogadicción | |
| US5807571A (en) | Transdermal therapeutic systems for administering indole serotonin agonists | |
| ES2255287T3 (es) | Composiciones para el tratamiento de la leucemia linfocitica cronica. | |
| RU98111639A (ru) | Применение эпинастина в качестве болеутоляющего средства | |
| ATE165973T1 (de) | Sumatriptan enthaltende arzneimittel | |
| JP2002540141A5 (https=) | ||
| CA2537748A1 (en) | Use of telmisartan for the prevention of vascular headache | |
| WO2001095903A1 (en) | 5-ht3 receptor antagonists for treatment of disorders involving airway constriction | |
| WO2001095902A9 (en) | A composition comprising a combination of receptor agonists and antagonists | |
| CN1155379C (zh) | 依利曲坦在制备预防偏头痛复发的药物中的应用 | |
| WO2002036113A1 (en) | Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4) | |
| US5705506A (en) | Pharmaceutical compositions of alkylsulphonamides 5HT1 agonists for rectal administration | |
| Rudd et al. | The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret | |
| US20040241159A1 (en) | Uses | |
| JP2002525327A5 (https=) | ||
| CA2328074A1 (en) | Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors | |
| US20020099059A1 (en) | Combination therapy for the treatment of migraine | |
| JP2009535336A (ja) | 片頭痛治療用の固定組合せ剤形 | |
| IE55189B1 (en) | Pharmaceutical compositions | |
| HUP0401696A2 (hu) | Angiotenzin-II receptor antagonistát tartalmazó gyógyászati készítmény | |
| HK1064618A (en) | A composition for preventing migraine recurrence |